White Papers

  1. Empower Your Trial With Data And Evidence 1/14/2026

    Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.

  2. A New, AI-Augmented Horizon For Safety And Pharmacovigilance 1/6/2026

    Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.

  3. Addressing Trial Design Hurdles Across Alzheimer’s Disease Stages 12/10/2025

    Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

  4. Digital Endpoint Resource Guide: Sleep Disorders 12/10/2025

    Sensor-driven digital endpoints track sleep patterns and disruptions, standardize trial outcomes, and enable remote monitoring that reduces patient burden while improving treatment-response insights.

  5. Clinical Trial Starts Rose At Slower Pace In 2024 12/8/2025

    Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.

  6. Human-Centered RTSM Design Enhances Data, Safety, And Operations 12/5/2025

    Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.

  7. Endpoint Clinical RTSM: Getting The Job Done 12/5/2025

    Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.

  8. The Real Cost In CNS Trials: Rater Drift And Site Readiness 11/21/2025

    Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.

  9. ICH GCP E6(R3) Implementation: Practical Approaches And Real-World Considerations 11/21/2025

    Access the full brief to learn how a phased, 12–18-month approach can help you meet ICH GCP E6(R3) requirements with confidence and avoid the costly pitfalls many organizations overlook.

  10. Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials 11/21/2025

    This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.